Cervical Length and Bishop Score in Preinduction Cervical Assessment Prior to Induction of Labor

NCT ID: NCT02694315

Last Updated: 2016-11-07

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-10-31

Study Completion Date

2016-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Comparison between Sonographic Cervical Length and Bishop Score in Preinduction Cervical Assessment prior to induction of labor as regards induction success.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Type of the study:

assessment of accuracy of diagnostic test.

Study setting:

The study will be performed at Ain Shams university Maternity hospital on nulliparous women at term admitted to causality for induction of labor.

Study population:

The study will be held on 200 women all are primigravida between 37-42 weeks gestation to whom induction of labor will be carried out in the casualty of Ain Shams University Maternity Hospital.

All patients will have cervical assessment by modified Bishop score and cervical length measurement by ultrasound.

Plan for induction of labor:

* Detailed and careful history will be taken from the participants as follows:

1. Personal history: including name, age, occupation, residence and special habits of medical importance.
2. Obstetric history: including gestational age and regular antenatal care.
3. Past history: including any medical disorder e.g Diabetes mellitus, hypertension or any surgical procedure.
4. History of present pregnancy: duration of pregnancy from last menstrual period, any complications occurred or any medication used during pregnancy.
* Examination of the participants:

1. General examination: level of consciousness, vital data, complexion.
2. Abdominal examination: fundal level, lie of the fetus, detection of any uterine contractions and fetal heart rate.
3. Pelvic Examination : presenting part, presence of ruptured membranes and cervical assessment as regard cervical dilation, effacement, station and presenting part to calculate the modified Bishop Score.
* Investigations: complete blood count, blood group, non stress test.
* All women will have trans-vaginal ultrasound sound for assessment of cervical length.
* Protocol of trans-vaginal ultrasound will be as follows:

1. Patient will be asked to void.
2. Vaginal probe will be inserted using direct visualization.
3. Identification of bladder and fetal presenting part.
4. Identification of abnormal findings as placenta previa or absence of fetal heart motion.
5. Identification of mid-line sagittal plane of the cervix and looking in the proximal one third of the image for the internal cervical os then pulling back the probe until the lightest touch provides good image of the cervical canal and moving the probe slightly to get the best long axis of the cervix then measuring the cervical length three times by placing the calibers appropriately and recording the distance between internal and external os then at last recording the measurement of the best image .
* If cervical length assessed by trans-vaginal ultrasound is less than 28 mm or modified Bishop Value is less than 7, the patient will receive 3mg prostaglandin E2 for pre-induction cervical ripening to be repeated after 6 hours with maximum of 2 doses. If failed cervical ripening, Cesarean section will be done.
* All Patients will be tested by antepartum fetal heart monitoring "Non stress test".This will be considered reactive if there are two or more fetal heart rate accelerations peaking at least by 15 beats/min above the baseline and lasting for 15 seconds or more from baseline, within a 20 minutes period, with or without fetal movement felt by the mother. A non-reactive tracing will be one without sufficient fetal heart rate accelerations over a 40 minutes period. Any patient with non-reassuring non stress test will be excluded.
* Successful induction will be defined as vaginal delivery within 24 hours.
* Failed induction after 24 hours will indicate lower segment cesarean section. Failed induction will be defined as an inability to achieve the active phase of labor corresponding to a cervical dilatation ≥4 cm within 12 hours of initiating oxytocin. Failure of progress was defined as no cervical dilatation during the active phase of labor for at least 2 hours or no descent of the fetal head during the second stage of labor for at least 1 hour despite adequate uterine contraction. This will be considered an indication for cesarean delivery.
* No further induction agent will be given when uterine contractions reach frequency of three in ten minutes each lasting 30-60 seconds with cervical changes. Amniotomy and oxytocin augmentation will begin when cervical dilation becomes \> 3 cm.
* Oxytocin infusion will be prepared by placing 5 IU ampoule in 500 ml Ringer or Saline to achieve concentration of 10 ml\\minute.
* The rate of infusion will be started at a rate of 5 miu/ml (about 10 drops per minute) and will be increased at same increment every 20 minutes according to uterine contractions.
* When the patient become in the active phase of labor, vaginal examination will be repeated every 1-2 hours to know the rate of cervical dilation.
* If patient requests pain relieve, epidural analgesia will be used.
* Fetal heart rate will be recorded every half an hour.
* Labor progress will be plotted on partogram.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cervical Dystocia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Induction of labor

200 women all are primigravida between 37-42 weeks gestation to whom induction of labor will be carried out in the casualty of Ain Shams University Maternity Hospital. All participants will have an assessment of the cervix by both Bishop score system and transvaginal measurement of cervical length.

Bishop score

Intervention Type OTHER

calculation of modified Bishop score in numbers by digital vaginal examination

cervical length

Intervention Type OTHER

measuring cervical length by trans-vaginal ultrasound

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bishop score

calculation of modified Bishop score in numbers by digital vaginal examination

Intervention Type OTHER

cervical length

measuring cervical length by trans-vaginal ultrasound

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Nulliparous patients.
2. Singleton pregnancy.
3. Living fetus with cephalic presentation.
4. Absence of labor pain.
5. Gestational age 37-42 weeks.
6. No previous uterine surgical procedures.
7. No Liquor abnormalities.
8. Fetal weight less than 4 kilograms.

Exclusion Criteria

1. Non-vertex presentation.
2. Previous uterine surgery.
3. Multiple pregnancy.
4. Fetal or maternal complications that might cause cesarean section.
5. Liquor abnormalities.
6. Fetal weight more than 4 kilograms.
7. Abnormal umbilical artery Doppler indices or non-stress test.
8. Asthmatic patients or women with allergy to prostaglandins.
Minimum Eligible Age

17 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ain Shams Maternity Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Amr Ahmed Mahmoud Riad

Lecturer of obstetrics and gynecology

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ain Shams maternity hospital

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

sonographic cervical length

Identifier Type: -

Identifier Source: org_study_id